Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.80
+0.05 (0.87%)
Jun 27, 2025, 4:00 PM - Market closed
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$282,047
Profits / Employee
-$121,861
Market Cap
478.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VALN News
- 2 days ago - Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus - GlobeNewsWire
- 3 days ago - Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance - GlobeNewsWire
- 19 days ago - UK's MHRA suspends Valneva's chikungunya vaccine for elderly - Reuters
- 23 days ago - Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 24 days ago - Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Valneva to Participate at U.S. and European Investor Conferences in June - GlobeNewsWire
- 6 weeks ago - Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States - GlobeNewsWire
- 7 weeks ago - Valneva SE (VALN) Q1 2025 Earnings Call Transcript - Seeking Alpha